RYVU THERAPEUTICS S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.5 PLN | -0.59% |
|
-5.61% | -12.17% |
Chart calendar Ryvu Therapeutics S.A.
16ed309261cf1a41a9ce.s3XQ9vDjxKDQl2crtcDiD4M5cJd-LS1E2dy-nC_x87U.-QfhwIGnofG9xw9N96-oRtVQFuEbT0cXm432rGzFnIbCIOa7laaH-ZHQMg~4e12cd6cb6201bbc5a832dd796f12e1c
Upcoming events on Ryvu Therapeutics S.A.
Past events on Ryvu Therapeutics S.A.
| 2024-04-10 09:00 am | American Association for Cancer Research Meeting - Poster Number: 7225 |
| 2024-04-09 01:30 pm | American Association for Cancer Research Meeting - Poster Number: 5942 |
| 2024-04-09 09:00 am | American Association for Cancer Research Meeting - Poster Number: 4598 |
| 2024-04-09 09:00 am | American Association for Cancer Research Meeting - Poster Number: 4684 |
| 2024-04-07 01:30 pm | American Association for Cancer Research Meeting - Poster Number: 665 |
| 2024-04-04 | American Association for Cancer Research Meeting |
| 2024-03-13 04:37 am | Q4 2023 Earnings Release |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster No - 4173 |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Poster Number : 4175 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster Number : 2800 |
| 2023-12-11 02:00 am | American Society of Hematology Meeting |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster Number : 3225 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Poster Number : 2913 |
| 2023-12-08 | American Society of Hematology Meeting |
| 2023-12-07 06:00 pm | San Antonio Breast Cancer Symposium - Poster Number: PO4-14-01 |
| 2023-12-04 | San Antonio Breast Cancer Symposium |
| 2023-11-29 11:30 am | Q3 2023 Earnings Release |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-23 03:00 am | Business Update Call |
| 2023-10-19 | European Society for Medical Oncology Congress |
Past dividends on Ryvu Therapeutics S.A.
| 2019-10-08 | 0 PLN |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million PLN | Released Forecast Spread | 37,0 | 37,0 35,1 5.27% | 37,1 27,2 36.32% | 68,4 113 -39.47% | 67,3 66,1 1.86% | 152 |
|
EBITDA Million PLN | Released Forecast Spread | 0,00 | -23,3 -27,6 15.47% | -65,3 -51,8 -26.07% | -65,5 -11,0 -493.86% | -90,0 -84,7 -6.29% | -82,6 |
|
EBIT Million PLN | Released Forecast Spread | 0,00 | -35,7 -36,6 2.54% | -77,9 -71,2 -9.36% | -78,4 -31,9 -146.09% | -101 -103 1.87% | -160 |
|
Earnings before Tax (EBT) Million PLN | Released Forecast Spread | 0,00 | -30,6 -36,7 16.47% | -77,4 -71,2 -8.81% | -79,2 -33,8 -134.3% | -92,1 -107 14.07% | -161 |
|
Net income Million PLN | Released Forecast Spread | 0,00 | -31,7 -36,8 13.93% | -77,5 -71,2 -8.97% | -83,8 -36,3 -130.59% | -92,1 -101 8.44% | -161 |
|
EPS PLN | Released Forecast Spread | 0,00 | -1,89 -2,14 11.68% | -4,22 -4,15 -1.78% | -4,60 -0,65 -613.18% | -4,02 -4,10 1.95% | -4,00 |
| Announcement Date | 09/04/20 | 16/03/21 | 15/03/22 | 24/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million PLN | Released Forecast Spread | 34,6 101 -65.59% | 18,3 17,6 4.36% | 15,3 14,0 8.96% | 16,2 | 17,7 17,9 -1.08% | 24,5 | |
|
EBITDA Million PLN | Released Forecast Spread | 2,24 68,5 -96.73% | -11,5 -10,9 -5.94% | -24,6 -22,0 -11.86% | -24,3 -21,5 -12.96% | -17,3 | ||
|
EBIT Million PLN | Released Forecast Spread | -0,68 65,2 -101.05% | -18,1 -17,6 -2.86% | -31,6 -29,3 -7.99% | -26,9 -27,7 2.83% | -20,3 | ||
|
Net income Million PLN | Released Forecast Spread | -11,8 | -8,53 60,1 -114.18% | -17,6 -16,2 -8.62% | -28,5 -27,3 -4.42% | -18,3 | -27,8 -26,0 -6.75% | -17,8 |
|
EPS PLN | Released Forecast Spread | -0,64 | -0,79 | |||||
| Announcement Date | 23/11/22 | 24/03/23 | 16/05/23 | 13/09/23 | 29/11/23 | 13/03/24 | - |
More events
Past sector events for Ryvu Therapeutics S.A.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RVU Stock
- Calendar Ryvu Therapeutics S.A.
